These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 37894746)

  • 1. The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis.
    Xu L; Yan X; Wang J; Zhao Y; Liu Q; Fu J; Shi X; Su J
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.
    Meng F; Sun G; Zhong M; Yu Y; Brewer MA
    Int J Oncol; 2013 Aug; 43(2):495-502. PubMed ID: 23709006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of histone deacetylases (HDACs) in human cancer.
    Ropero S; Esteller M
    Mol Oncol; 2007 Jun; 1(1):19-25. PubMed ID: 19383284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer.
    Feng W; Lu Z; Luo RZ; Zhang X; Seto E; Liao WS; Yu Y
    Int J Cancer; 2007 Apr; 120(8):1664-8. PubMed ID: 17230502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics.
    Gallinari P; Di Marco S; Jones P; Pallaoro M; Steinkühler C
    Cell Res; 2007 Mar; 17(3):195-211. PubMed ID: 17325692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications.
    Li Z; Zhu WG
    Int J Biol Sci; 2014; 10(7):757-70. PubMed ID: 25013383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Histone Deacetylases in Monocyte Function in Health and Chronic Inflammatory Diseases.
    Tordera RM; Cortés-Erice M
    Rev Physiol Biochem Pharmacol; 2021; 180():1-47. PubMed ID: 33974124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
    Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
    Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of HDACs--effective drugs against cancer?
    Müller S; Krämer OH
    Curr Cancer Drug Targets; 2010 Mar; 10(2):210-28. PubMed ID: 20201785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of HDACs in normal and malignant hematopoiesis.
    Wang P; Wang Z; Liu J
    Mol Cancer; 2020 Jan; 19(1):5. PubMed ID: 31910827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism].
    Rahimian A; Barati G; Mehrandish R; Mellati AA
    Mol Biol (Mosk); 2018; 52(3):474-481. PubMed ID: 29989579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The important role of histone deacetylases in modulating vascular physiology and arteriosclerosis.
    Zhao TC; Wang Z; Zhao TY
    Atherosclerosis; 2020 Jun; 303():36-42. PubMed ID: 32535412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential molecular mechanistic behavior of HDACs in cancer progression.
    Singh T; Kaur P; Singh P; Singh S; Munshi A
    Med Oncol; 2022 Aug; 39(11):171. PubMed ID: 35972597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylases function as novel potential therapeutic targets for cancer.
    Zhang H; Shang YP; Chen HY; Li J
    Hepatol Res; 2017 Feb; 47(2):149-159. PubMed ID: 27457249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma.
    Yang Q; Falahati A; Khosh A; Mohammed H; Kang W; Corachán A; Bariani MV; Boyer TG; Al-Hendy A
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of dietary histone deacetylases (HDACs) inhibitors in health and disease.
    Bassett SA; Barnett MP
    Nutrients; 2014 Oct; 6(10):4273-301. PubMed ID: 25322459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone Deacetylases (HDACs) in Gastric Cancer: An Update of their Emerging Prognostic and Therapeutic Role.
    Schizas D; Mastoraki A; Naar L; Tsilimigras DI; Katsaros I; Fragkiadaki V; Karachaliou GS; Arkadopoulos N; Liakakos T; Moris D
    Curr Med Chem; 2020; 27(36):6099-6111. PubMed ID: 31309879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylases: a saga of perturbed acetylation homeostasis in cancer.
    Parbin S; Kar S; Shilpi A; Sengupta D; Deb M; Rath SK; Patra SK
    J Histochem Cytochem; 2014 Jan; 62(1):11-33. PubMed ID: 24051359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc-Dependent Histone Deacetylases in Lung Endothelial Pathobiology.
    Patil RS; Maloney ME; Lucas R; Fulton DJR; Patel V; Bagi Z; Kovacs-Kasa A; Kovacs L; Su Y; Verin AD
    Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of Histone Acetyltransferases and Deacetylases in the Retinal Development and Diseases.
    Wang J; Feng S; Zhang Q; Qin H; Xu C; Fu X; Yan L; Zhao Y; Yao K
    Mol Neurobiol; 2023 Apr; 60(4):2330-2354. PubMed ID: 36637745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.